Herbalife goes private
This article was originally published in The Tan Sheet
Executive Summary
Supplement direct marketer's stock delisted from NASDAQ July 31 upon same-day shareholder approval, completion of $685 mil. transaction to take company private. Holders of approximately 73.9% of all shares of voting common stock gave their consent to the transaction, with stockholders receiving $19.50 per share. Herbalife was acquired by an investor group led by equity firms Whitney & Co. and Golden Gate Capital, in partnership with direct marketer's distributors, senior management. Whitney Chairman & Managing Partner Peter Castleman is new chairman of Herbalife, while Francis Tirelli remains president, CEO. Transaction brings closure to almost three-year effort initiated by late founder Mark Hughes to take the firm private (1"The Tan Sheet" April 15, 2002, p. 5)...
You may also be interested in...
New Herbalife CEO
Michael Johnson succeeds Francis Tirelli as CEO effective April 14, direct marketer announces. Johnson is a 17-year veteran of Walt Disney Corporation, where he most recently served as president of Walt Disney International. Herbalife was taken private July 31 after acquisition by an investor group led by equity firms Whitney & Co., Golden Gate Capital, Herbalife senior management (1"The Tan Sheet" Aug. 5, 2002, In Brief). Tirelli resigned from CEO post in September to pursue other opportunities...
Herbalife Buyout By Equity Groups Achieves Long-Sought Private Ownership
The pending acquisition of Herbalife by equity firms Whitney & Co. and Golden Gate Capital ends a two-and-a-half year effort, initiated by late founder and CEO Mark Hughes, to take the direct marketer private
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.